Central Hospital, Nancy, France: COVID-19 trials

The registry lists 31 COVID-19 studies with Central Hospital, Nancy, France as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 2 1No phase 30(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Evaluation of the Effectiveness of a Spa Treatment for People With Post-Covid 19 Conditions.Not yet recruitingNCT06570239Not applicable
• Post-Covid Condition Cohort: Evolution of Symptomatology, Patient Profile and Associated Prognostic FactorsRecruitingNCT05610436
• SARS-CoV-2 in Stools Compared to Respiratory Viral Strains.Not yet recruitingNCT05567419
• Bank of Human Leukocytes From COVID-19 Convalescent Donors With an Anti-SARS-CoV-2 Cellular ImmunityRecruitingNCT05458440Not applicable
• Pseudomonas Aeruginosa Infections Among COVID-19 Patients in Intensive Care Units at CHRU of Nancy (Pyo-COVID-3)CompletedNCT06141837
• Factors Associated With Failure of HFNO in COVID-19 ICU PatientsStatus unknownNCT05798234
• Relationship Between Hyperventilation Syndrome and SARS-CoV-2 InfectionCompletedNCT05224830
• Impact of SARS-Cov2 Pandemic on Severity of Perioperative Complications in Patients Undergoing AppendectomyCompletedNCT05178251
• Impact of Antiphospholipid Antibodies on Thrombin Generation During Sars-CoV2 Infection (TACIT2 Study)Status unknownNCT05128760
• Impact of COVID-19 Pandemic on Allogeneic Stem Cell Transplantation Organization : a French ExperienceCompletedNCT05088941
• SaRS-Cov-2 Antibodies Following Exposure to Coronavirus Disease 2019 (COVID-19) and/or Vaccination in Nursing HomesCompletedNCT04964024
• Comparison of ARDS COVID-19 (WHO) vs ARDS Influenza in the ICUCompletedNCT04941092
• Analysis of SARS-CoV2 Urine Viral Particles and Association With Proximal Tubular DysfunctionStatus unknownNCT04937712
• Cognitive and Psychological Disorders After Severe COVID-19 InfectionCompletedNCT04937582Not applicable
• Prediction of Thrombosis Using D-dimer Trends in COVID-19CompletedNCT04827160
• Characterization in 18F-FDG PET-CT of Brain and Lung Lesions in Subjects With a History of Severe COVID-19CompletedNCT04764721Not applicable
• Multimodal IMAgery Characterization of Cardiac Damage and Severity After COVID-19 InfectionCompletedNCT04753762
• Tracheobronchitis in Respiratory Involvement on the Lung SPECT/CT Images of Coronavirus Disease (COVID-19) PatientsCompletedNCT04629222
• Efficacy of Infusions of MSC From Wharton Jelly in the SARS-Cov-2 (COVID-19) Related Acute Respiratory Distress SyndromeCompletedNCT04625738Phase 2
• Effect of Corticosteroid Treatment on Prognosis in ARDS Secondary to Covid-19Status unknownNCT04586114
• TREM-1 Pathway Activation in COVID-19CompletedNCT04544891
• CT Abnormalities Evocative of Lung Infection Are Associated With Lower 18F-FDG Uptake in Confirmed COVID-19 PatientsCompletedNCT04512118
• Assessing the Impact of the COVID-19 Lockdown on Metabolic Control and Access to Health Care in Patients With DiabetesStatus unknownNCT04485351
• FilmArray and Management of ICU Patients With Pneumonia in the Covid-19 ContextStatus unknownNCT04453540
• Nutritional Follow up After Hospital Discharge for Coronavirus Disease-19Status unknownNCT04451694
• Obesity and Mortality of Critically Ill Patients With COVID-19CompletedNCT04425213
• Evaluation of Airway Pressure Release Ventilation in COVID-19 ARDSCompletedNCT04386369
• Almitrine and COVID-19 Related HypoxemiaCompletedNCT04380727
• Predicting the Need for Intubation in Hospitalised COVID-19 Patients (PRED ICU COVID19)CompletedNCT04376879
• Cardiovascular and Renal Biomarkers to Predict Acute Heart or Kidney Injury in Severe Covid-19 InfectionCompletedNCT04354610Not applicable
• Birth Experience During COVID-19 ConfinementCompletedNCT04348929Not applicable